Just Released by Dr. Douglas

Are you suffering from chronic fatigue, lack of energy, high cholesterol, heart disease, over stress?   Find the keys to vibrant health… and transform your health in 30 days!

 

Personal Transformation

Increase your resistance to age-related illnesses such as cardiovascular disease and cancer. We believe that the most effective means is through complete immersion in a transformational program.

Meals Made Simple- balanced nutritional/diet solutions for busy persons. Wholesome, delicious meals are chef prepared and delivered fresh to your door.

read more

 

Curriculum Vita Dr. Donna-Beth Douglas

 

 

EDUCATION:

           

            Fellowship

Johns Hopkins University School of Medicine. (Oncology)

 

Doctor of Philosophy

Ohio State University, Columbus, OH  (Biochemistry)                             

 

Dissertation:  “Biologic Effects of Antipeptide Antibodies on the Her-2/neu Receptor Tyrosine Kinase: Implications for Therapy of Human Breast Cancer@

(This vaccine is currently in clinical trials)

           

Bachelor of Science

Magna Cum Laude. Oakwood College, Huntsville, AL  (Biochemistry)

   

PROFESSIONAL ACTIVITIES

            Founder, Director,  Douglas Cancer Institute, N. Palm Beach, FL

            Adjunct Professor, Dept.  of Chemistry, CCBC, Catonsville, MD

            Assistant Professor, Dept.  of Chemistry, Oakwood College, Huntsville, AL

            Member, Johns Hopkins Medical and Surgical Association

            Member, Monumental Medical Society

            Member, American Association for Cancer Research

            

PUBLISHED BOOKS AND PAPERS:

 

Douglas, D.  Hope on the Horizon:  Breakthrough Natural Solutions for Preventing and Reversing Chronic Disease, ISBN 978-1-84728-849-3. Lulu Publishing, www.lulu.com/donnajhu (2006).

 

Douglas, D., Akiyama, Y., Carraway, H., Belinsky, S., Esteller, M., Gabrielson, E., Weitzman, S., Williams, T., Herman, J., Baylin, S. (2004) Hypermethylation of a small CpGuanine rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer.  Cancer Research 64, 1611 – 1620. 

 

Dakapaggari, N., Douglas, D., Triozzi, P., Stevens,V. and P.T.P. Kaumaya. (2000)  Prevention of Mammary Tumors with a Chimeric HER-2 B-cell Epitope Peptide Vaccine. Cancer Research 60, 3782-3789.

 

Corn, P., Smith, B.D., Ruckdeschel, E.S.,   Douglas,  D., Baylin, S.B. and Herman, J.G.  (2000) E-cadherin  Expression is Silenced by 5' CpG Island Methylation in Acute Leukemia. Clinical Cancer Research, 6(11),  4243-8.

 

Woodbine, D., Conrad, S.  DiGeorge, A. M. and P.T.P.  Kaumaya.(1996) Positioning of Promiscuous T Cell Epitopes on a single Matrix, Multicomponent Combination Vaccine In Elucidation of  MHC-Unrestricted Responses. In PEPTIDES: Chemistry,   Structure and Biology (Kaumaya, P.T.P and Hodges,  R.S., Eds.)Mayflower Scientific Ltd.

 

Woodbine, D.,   Aldrich, W.,  Triozzi, P.,   Stevens, V.  and P.T.P. Kaumaya. (1996) Peptide Vaccine Strategy for Immunotherapy of Human Breast Cancer Using the Her-2/neu Oncogene.In PEPTIDES: Chemistry, Structure and Biology (Kaumaya, P.T.P and Hodges, R.S., Eds.) Mayflower Scientific Ltd.

 

 

SELECTED PRESENTATIONS

            Scientific Advisor: State of Maryland House of Representatives

            BWLC National Convention,  Baltimore, MD

           State of Maryland Leadership Conference, Zeta Phi Beta

            14th American Peptide Symposium

            15th American Peptide Symposium

            Los Alamos National Lab

2007 © Copyright Dr. Donna Douglas. All rights reserved.
All rights reserved.